-
EP2854824
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2854824
| EP2854824 - USE OF KERATINOCYTES AS A BIOLOGICALLY ACTIVE SUBSTANCE IN THE TREATMENT OF WOUNDS, SUCH AS DIABETIC WOUNDS, OPTIONALLY IN COMBINATION WITH A DPP-4 INHIBITOR [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 22.12.2017 Database last updated on 07.06.2024 | |
| Former | Examination is in progress Status updated on 21.02.2017 | Most recent event Tooltip | 22.12.2017 | Application deemed to be withdrawn | published on 24.01.2018 [2018/04] | Applicant(s) | For all designated states Boehringer Ingelheim International GmbH Binger Strasse 173 55216 Ingelheim am Rhein / DE | [N/P] |
| Former [2015/15] | For all designated states Boehringer Ingelheim International GmbH Binger Strasse 173 55216 Ingelheim am Rhein / DE | Inventor(s) | 01 /
KLEIN, Thomas Boehringer Ingelheim GmbH Corporate Patents Binger Strasse 173 55216 Ingelheim am Rhein / DE | 02 /
MARK, Michael Boehringer Ingelheim GmbH Corporate Patents Binger Strasse 173 55216 Ingelheim am Rhein / DE | [2015/15] | Representative(s) | Simon, Elke Anna Maria, et al Boehringer Ingelheim GmbH Binger Strasse 173 55216 Ingelheim am Rhein / DE | [2015/15] | Application number, filing date | 13726702.7 | 17.05.2013 | WO2013EP60312 | Priority number, date | EP20120004077 | 25.05.2012 Original published format: EP 12004077 | [2015/15] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2013174769 | Date: | 28.11.2013 | Language: | EN | [2013/48] | Type: | A1 Application with search report | No.: | EP2854824 | Date: | 08.04.2015 | Language: | EN | The application published by WIPO in one of the EPO official languages on 28.11.2013 takes the place of the publication of the European patent application. | [2015/15] | Search report(s) | International search report - published on: | EP | 28.11.2013 | Classification | IPC: | A61K35/12, C12N5/071 | [2015/15] | CPC: |
A61K35/36 (EP,US);
A61K31/522 (US);
A61K45/06 (US);
A61K9/7007 (US);
A61P17/02 (EP);
A61P3/10 (EP);
A61P43/00 (EP);
C12N5/0629 (EP,US);
C12N2500/25 (EP,US);
C12N2500/40 (EP,US);
C12N2501/01 (EP,US);
C12N2501/11 (EP,US);
C12N2501/39 (EP,US);
C12N2501/395 (EP,US);
C12N2502/13 (EP,US);
C12N2533/80 (EP,US)
(-)
| C-Set: |
A61K35/36, A61K2300/00 (EP,US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/15] | Title | German: | VERWENDUNG VON KERATINOZYTEN ALS EINER BIOLOGISCH AKTIVE SUBSTANZ IN DER BEHANDLUNG VON WUNDEN WIE DIABÄTISCHE WUNDEN, GEGEBENENFALLS IN KOMBINATION MIT EINEM DPP-4-HEMMER | [2015/15] | English: | USE OF KERATINOCYTES AS A BIOLOGICALLY ACTIVE SUBSTANCE IN THE TREATMENT OF WOUNDS, SUCH AS DIABETIC WOUNDS, OPTIONALLY IN COMBINATION WITH A DPP-4 INHIBITOR | [2015/15] | French: | UTILISATION DE KÉRATINOCYTES EN TANT QUE SUBSTANCE BIOLOGIQUEMENT ACTIVE DANS LE TRAITEMENT DES PLAIES, PAR EXEMPLE DES PLAIES DIABÉTIQUES, FACULTATIVEMENT EN COMBINAISON AVEC UN INHIBITEUR DE LA DPP-4 | [2015/15] | Entry into regional phase | 05.01.2015 | National basic fee paid | 05.01.2015 | Designation fee(s) paid | 05.01.2015 | Examination fee paid | Examination procedure | 16.12.2014 | Amendment by applicant (claims and/or description) | 05.01.2015 | Examination requested [2015/15] | 13.11.2015 | Despatch of a communication from the examining division (Time limit: M06) | 13.05.2016 | Reply to a communication from the examining division | 10.02.2017 | Despatch of a communication from the examining division (Time limit: M06) | 22.08.2017 | Application deemed to be withdrawn, date of legal effect [2018/04] | 18.09.2017 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2018/04] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 13.11.2015 | Fees paid | Renewal fee | 01.06.2015 | Renewal fee patent year 03 | 31.05.2016 | Renewal fee patent year 04 | 31.05.2017 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]WO9846082 (UNIV MICHIGAN [US]) [Y] 1-28 * abstract * * page 10, line 1 - line 20 * * page 32; claim 22 *; | [YD]WO03033686 (BOEHRINGER INGELHEIM PHARMA [DE], et al) [YD] 1-28 * abstract * * page 3, line 25 - line 29 * * page 4, line 4 - line 13 * * page 24; claims 17,21 * * page 25; claim 23 *; | [Y]WO2010018217 (BOEHRINGER INGELHEIM INT [DE], et al) [Y] 1-28 * abstract * * page 9, line 18 - line 24 *; | [Y]WO2011064352 (BOEHRINGER INGELHEIM INT [DE], et al) [Y] 1-28 * abstract ** page 94; example 20 * | by applicant | EP0296475 | WO9113638 | EP0462426 | US5298417 | WO9507611 | WO9624018 | US5891617 | WO02068420 | WO03033686 | WO2004018468 | WO2004050658 | WO2005085246 | WO2005110999 | WO2006029769 | WO2006048427 | WO2006068163 | WO2007071738 | WO2007128721 | WO2007128724 | WO2008017670 | WO2009121945 | - EELE H; NAEYAERT JM; GOETEYN M; DE MIL M; KINT A, "Repeated cultured epidermal allografts in the treatment of chronic leg ulcers of various origins", DERMATOLOGICA, (1991), vol. 183, no. 1, pages 31 - 5 | - DE LUCA M; ALBANESE E; CANCEDDA R; VIACAVA A; FAGGIONI A; ZAMBRUNO G; GIANNETTI A, "Treatment of leg ulcers with cryopreserved allogeneic cultured epithelium. A multicenter study", ARCHIVES OF DERMATOLOGY, (1992), vol. 128, no. 5, pages 633 - 8 | - HARLE-BACHOR C; BOUKAMP P, "Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes", PNAS, (1993), vol. 93, pages 6476 - 6481 | - FALANGA V ET AL., "Rapid Healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent", ARCHIVES OF DERMATOLOGY, (1998), vol. 134, pages 293 - 300 | - HARRIS PA; DI FRANNCESCO F; BARISONI D; LEIGH IM; NAVASARIA, "Use of hyaluronic acid and cultured autologous keratinocytes and fibroblasts in extensive burns", LANCET, (1999), vol. 353, pages 35 - 36 | - KSWAI K; IKARASHI Y ET AL., "Rejection of cultured keratinocyte allografts in persensitized mice", TRANSPLANTATION, (1993), vol. 56, pages 265 - 269 | - LAM PK; CHAN ESY; EDWARD WH ET AL., "Development and evaluation of a new composite Laserskin graft", J. OF TRAUMA: INJURY, INFECTION AND CRITICAL CARE, (1999), vol. 47, pages 918 - 922 | - LANG E; SCHÄFER BM; EICKHOFF U; HOHL HP; KRAMER, M D; MAIER-REIF K, "Rapid Normalization of epidermal integrin expression after allografting of human keratinocytes", JOURNAL OF INVESTIGATIVE DERMATOLOGY, (1996), vol. 107, pages 423 - 427 | - "Clinical practice and biological effects of keratinocyte grafting.", LEIGH IM; NAVSARIA H; PURKIS PE; MCKAY I, Annals of the Academy of Medicine, (1991), vol. 20 | - LINDGREN C; MARCUSSON JA; TOFTGARD R, "Treatment of venous leg ulcers with cryopreserved cultured allogeneic keratinocytes: a prospective open controlled study", BRITISH JOURNAL OF DERMATOLOGY, (1998), vol. 139, no. 2, pages 271 - 5 | - MAIER K, "Transplantation von in vitro Epidermis - Chancen and Risiken", QUINTESSENZ, (1993), vol. 3, pages 289 - 304 | - PHILLIPS TJ; GILCHREST BA, "Cultured allogenic keratinocyte grafts in the management of wound healing: prognostic factors", JOURNAL OFDERMATOLOGIC SURGERY AND ONCOLOGY, (1989), vol. 15, no. 11 | - REINWALD, JG; GREEN, "Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells", CELL, (1975), vol. 6, pages 331 - 344 | - SCHONFELD M; MOLL I; MAIER K; JUNG EG, "Keratinozyten aus der Zellkultur zur Therapie von Hautdefekten", HAUTARZT, (1993), vol. 44, pages 281 - 289 | - SCHOPP VM; MIRANCEA N; FUSENIG NE., "Epidermal Organization and Differentiation of HaCaT Keratinocytes in Organotypic Coculture with Human dermal Fibroblasts", J. INVEST. DERMATOLOGY, (1999), vol. 112, pages 343 - 353 | - TANCZOS E; HORCH RE; BANNASCH H; ANDREE C; WALGENBACH KJ; VOIGT M; STARK GB, "Keratinozytentransplantation and Tissue Engineering. Neue Ansatze in der Behandlung chronischer Wunden", ZENTRALBL CHIR, (1999), vol. 124, no. 1, pages 81 - 86 | - TEEPE RGC; ROSEEUW DI; HERMANS J.; KOEBRUGGE EJ; ALTENA T; DE CONINCK A; PONEC M; JAN VERMEER B, "Randomized trial comparing cryopreserved cultured epidermal allografts with hydrocolloid dressings in healing chronic venous ulcers", JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, (1993), vol. 29/6, pages 982 - 988 | - WAGNER G; HORCH R; DEBUS M; TANCZOS E; JIAO XJ; SAIED S; STARK G.B., "Human keratinocytes cultured subconfluent on esterified hyaluronic acid membranes for resurface full thickness nude mice wounds", EUROPEAN JOURNAL OF CELL BIOLOGY, (1997), vol. 74, no. 47, page 61 |